Veterinary Medicines

COBACTAN 2.5% w/v suspension for injection for cattle and pigs

Authorised
  • Cefquinome sulfate
Download as PDF

Product identification

Medicine name:
COBACTAN 2.5% w/v suspension for injection for cattle and pigs
Cobactan 2,5 % w/v Injektionssuspension für Rinder und Schweine
Active substance:
  • Cefquinome sulfate
Target species:
  • Cattle
  • Pig
Route of administration:
  • Intramuscular use

Product details

Active substance and strength:
  • Cefquinome sulfate
    29.64
    milligram(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Cattle
      • Meat and offal
        5
        day
      • Milk
        1
        day
    • Pig
      • Meat and offal
        3
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DE90
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Germany
Package description:
  • (ID2) 50 millilitre(s): unspecified outer container with 1 Bottle (Glass) with 50 millilitre(s)
  • (ID1) 100 millilitre(s): unspecified outer container with 1 Bottle (Glass) with 100 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Intervet Deutschland GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Intervet International GmbH
Responsible authority:
  • Federal Office Of Consumer Protection And Food Safety
Authorisation number:
  • 400743.00.00
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0309/001
Concerned member states:
  • Austria
  • Belgium
  • Italy
  • Luxembourg
  • Netherlands
  • Portugal
  • Spain

Documents

Combined File of all Documents

English (PDF)
Published on: 2/07/2024
Download
German (PDF)
Published on: 8/10/2024
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."